ALX Oncology Inc.

NASDAQ: ALXO · Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 1:19 PM

ALX Oncology Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.65 -3.98 -3.71 -10.38
PEG Ratio
0.02 -0.17 -0.08 -0.17
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.77 3.37 1.74 2.39
P/FCF Ratio
-0.71 -4.86 -5.06 -11.86
P/OCF Ratio
-0.71 -4.91 -5.14 -12.72
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.09 0.09 0.04 0.00
Quick Ratio
7.26 5.24 10.19 24.00
Current Ratio
7.26 5.24 9.57 24.00
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-82.4 -108.8 -535.45 -6.43K
Return on Equity
-1.19 -0.85 -0.47 -0.23
Return on Assets
-0.91 -0.66 -0.4 -0.22
Return on Invested Capital
-1.1 -0.81 -0.45 -0.23
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a